Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

British Journal of Haematology

Volumn 125, Issue 4, 2004, Pages 455-462

  Hoffmann, Christian ^a   Kai, Uwe Chow ^b   Wolf, Eva ^c   Faetkenheuer, Gerd ^d   Stellbrink, Hans Juergen ^e   Van Lunzen, Jan ^e   Jaeger, Hans ^c   Stoehr, Albrecht ^f   Plettenberg, Andreas ^f   Wasmuth, Jan Christian ^g   Rockstroh, Juergen ^g   Mosthaf, Franz ^h   Horst, Heinz August ^a   Brodt, Hans Reinhard ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c KIS Curatorium for Immunodeficiency   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f Ifl Inst Interdisc Infectiology I   (Germany)

^g UNIVERSITY OF BONN   (Germany)

^h Private Practice Karlsruhe   (Germany)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; Hodgkin's disease; Human immunodeficiency virus; Immune recovery

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REMISSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL TIME; VIRUS LOAD;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 3142699467     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04934.x     Document Type: Article

References (39)

1. Ames, E.D., Conjalka, M.S., Goldberg, A.F., Hirschman, R., Jain, S., Distenfeld, A. & Metroka, C.E. (1991) Hodgkin's disease and AIDS. Twenty-three new cases and a review of the literature. Hematology/Oncology Clinics of North America, 5, 343-356.
2. Andrieu, J.M., Roithmann, S., Tourani, J.M., Levy, R., Desablens, B., le Maignan, C., Gastaut, J.A., Brice, P., Raphael, M. & Tailan, B. (1993) Hodgkin's disease during HIV-1 infection: the French registry experience. French Registry of HIV-associated Tumors. Annals of Oncology, 4, 635-641.
3. Antinori, A., Cingolani, A., Alba, L., Ammassari, A., Serraino, D., Ciancio, B.C., Palmieri, F., De Luca, A., Larocca, L.M., Ruco, L., Ippolito, G. & Cauda, R. (2001) Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to HAART. AIDS, 15, 1483-1491.
4. Bellas, C., Santon, A., Manzanal, A., Campo, E., Martin, C., Acevedo, A., Varona, C., Forteza, J., Morente, M. & Montalban, C. (1996) Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Comparison with ordinary Hodgkin's disease. The American Journal of Surgical Pathology, 12, 1520-1524.
5. Brodt, H.R., Kamps, B.S., Gute, P., Knupp, B., Staszewski, S. & Helm, E.B. (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS, 11, 1731-1738.
6. Carbone, A., Gloghini, A., Larocca, L.M., Antinori, A., Falini, B., Tirelli, U., Dalla-Favera, R. & Gaidano, G. (1999) Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. Blood, 93, 2319-2326.
7. Chapman, A.L., Rickinson, A.B., Thomas, W.A., Jarrett, R.F., Crocker, J. & Lee, S.P. (2001) Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Research, 61, 6219-6226.
8. Dolcetti, R., Boiocchi, M., Gloghini, A. & Carbone, A. (2001) Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. European Journal of Cancer, 37, 1276-1287.
9. Errante, D., Gabarre, J., Ridolfo, A.L., Rossi, G., Nosari, A.M., Gisselbrecht, C., Kerneis, Y., Mazzetti, F., Vaccher, E., Talamini, R., Carbone, A. & Tirelli, U. (1999) Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Annals of Oncology, 10, 189-195.
10. Franceschi, S., Dal Maso, L. & La Vecchia, C. (1999) Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. International Journal of Cancer, 83, 481-485.
11. Frisch, M., Biggar, R., Engels, EA. & Goedert, J.J. (2001) Association of cancer with AIDS-related immunosuppression in adults. The Journal of the American Medical Association, 285, 1736-1745.
12. Gérard, L., Galicier, L., Boulanger, E., Quint, L., Lebrette, M.G., Mortier, E., Meignin, V. & Oksenhendler, E. (2003) Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS, 17, 81-87.
13. Goedert, J.J. (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Seminars in Oncology, 27, 390-401.
14. Hasenclever, D. & Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease. New England Journal of Medicine, 339, 1506-1514.
15. Herndier, B.G., Sanchez, H.C., Chang, K.L., Chen, Y.Y. & Weiss, L.M. (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. American Journal of Pathology, 4, 1073-1079.
16. Hoffmann, C., Tabrizian, S., Wolf, E., Eggers, C., Stoehr, A., Plettenberg, A., Buhk, T., Stellbrink, H.J., Horst, H.A., Jager, H. & Rosenkranz, T. (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS, 15, 2119-2127.
17. Hoffmann, C., Wolf, E., Fätkenheuer, G., Bunk, T., Lorenzen, T., Stoehr, A., Plettenberg, A., Stellbrink, H.J., Jager, H., Siebert, U. & Horst, H.A. (2003) Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS, 17, 1521-1529.
18. International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. Journal of the National Cancer Institute, 92, 1823-1830.
19. Kostense, S., Otto, S.A., Knol, G.J., Manting, E.H., Nanlohy, N.M., Jansen, C., Lange, J.M., van Oers, M.H., Miedema, F. & van Baarle, D. (2002) Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. European Journal of Immunology, 32, 1080-1089.
20. Levine, A.M., Li, P., Cheung, T., Tulpule, A., Von Roenn, J., Nathwani, B.N. & Ratner, L. (2000) Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). Journal of Acquired Immune Deficiency Syndromes, 24, 444-450.
21. Little, R.F., Pittaluga, S., Grant, N., Steinberg, S.M., Kavlick, M.F., Mitsuya, H., Franchini, G., Gutierrez, M., Raffeld, M., Jaffe, E.S., Shearer, G., Yarchoan, R. & Wilson, W.H. (2003) Highly effective treatment of AIDS-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood, 101, 4653-6539.
22. Mocroft, A., Katlama, C., Johnson, A.M., Pradier, C., Antunes, F., Mulcahy, F., Chiesi, A., Phillips, A.N., Kirk, O. & Lundgren, J.D. (2000) AIDS across Europe, 1994-98: the EuroSIDA study. Lancet, 356, 291-296.
23. O'Sullivan, C.E., Peng, R., Cole, K.S., Montelaro, R.C., Sturgeon, T., Jenson, H.B. & Ling, P.D (2002) Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. Journal of Medical Virology, 67, 320-326.
24. Operskalski, E.A., Mosley, J.W., Busch, M.P. & Stram, D.O. (1997) Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 243-244.
25. Palella, Jr, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. & Holmberg, S.D. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
26. Rapezzi, D., Ugolini, D., Ferraris, A.M., Racchi, O. & Gaetani, G.F. (2001) Histological subtypes of Hodgkin's disease in the setting of HIV infection. Annals of Hematology, 80, 340-344.
27. Re, A., Casari, S., Cattaneo, C., Facchetti, F., Cadeo, G., Carosi, G. & Rossi, G. (2001) Hodgkin's disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin's lymphoma. Cancer, 92, 2739-2745.
28. Ree, H.J., Strauchen, J.A., Khan, A.A., Gold, J.E., Crowley, J.P., Kahn, H. & Zalusky, R. (1991) Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer, 67, 1614-1621.
29. Ribera, J.M., Navarro, J.T., Oriol, A., Lopez-Guillermo, A., Sureda, A., Abella, E., Hernandez-Rivas, J.A., Xicoy, B., Grau, J., Battle, M. & Feliu, E. (2002) Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease. AIDS, 16, 1973-1976.
30. Rubio, R. (1994) Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cancer, 73, 2400-2407.
31. Serrano, M., Bellas, C., Campo, E., Ribera, J., Martin, C., Rubio, R., Ruiz, C., Ocana, I., Buzon, L. & Yebra, M. (1990) Hodgkin's disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients. Cancer, 65, 2248-2254.
32. Sieber, M., Engert, A. & Diehl, V. (2000) Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group. Annals of Oncology, 11(Suppl. 1), 81-85.
33. Skiest, D.J., Rubinstien, E., Carley, N., Gioiella, L. & Lyons, R. (1996) The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. American Journal of Medicine, 101, 605-611.
34. Spina, M., Gabarre, J., Rossi, G., Fasan, M., Schiantarelli, C., Nigra, E., Mena, M., Antinori, A., Ammassari, A., Talamini, R., Vaccher, E., di Gennaro, G. & Tirelli, U. (2002) Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood, 100, 1984-1988.
35. Stevens, S.J., Blank, B.S., Smits, P.H., Meenhorst, P.L. & Middeldorp, J.M. (2002) High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS, 16, 993-1001.
36. Tesch, H., Sieber, M. & Diehl, V. (2001) Treatment of advanced stage Hodgkin's disease. Oncology, 60, 101-109.
37. Tirelli, U., Errante, D., Dolcetti, R., Gloghini, A., Serraino, D., Vaccher, E., Franceschi, S., Boiocchi, M. & Carbone, A. (1995) Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. Journal of Clinical Oncology, 13, 1758-1767.
38. Tsimberidou, A.M., Sarris, A.H., Medeiros, L.J., Mesina, O., Rodriguez, M.A., Hagemeister, F.B., Romaguera, J., Pro, B., McLaughlin, P., Dang, N. & Cabanillas, F. (2001) Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome. Leukemia and Lymphoma, 41, 535-544.
39. Van Baarle, D., Hovenkamp, E., Callan, M.F., Wolthers, K.C., Kostense, S., Tan, L.C., Niesters, H.G., Osterhaus, A.D., McMichael, A.J., van Oers, M.H. & Miedema, F. (2001) Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood, 98, 146-155.